T1	Participants 553 684	20 subjects who received two tablets of ViviScal once daily and 20 who received two tablets of fish extract once daily for 6 months
T2	Participants 686 749	The mean patient age and mean duration and severity of baldness
T3	Participants 788 801	Most patients
T4	Participants 1226 1253	patients receiving ViviScal
T5	Participants 1388 1421	ViviScal group, 19 (95%) subjects
T6	Participants 1595 1606	both groups
